Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911487675> ?p ?o ?g. }
- W2911487675 endingPage "538" @default.
- W2911487675 startingPage "528" @default.
- W2911487675 abstract "Abstract Based on the leukemia‐associated immunophenotypes (LAIPs), minimal residual disease (MRD) related to the outcome can be detected by multiparameter flow cytometry in acute myeloid leukemia (AML) patients. Although 0.1% was commonly used as a cutoff value, measurable MRD or MRD level below 0.1% has also been associated with prognostic significance and more sensitive thresholds (<0.1%) are required for improving AML prognosis prediction. In this study, 292 adult patients diagnosed with AML (non‐M3) were enrolled, 36 kinds of LAIPs were identified, and the baseline expression levels in normal or regenerating bone marrows of each kind of LAIP were established, which ranged from <2.00 × 10 −5 to 5.71 × 10 −4 . The baseline level of each LAIP was considered as the individual threshold for MRD assessment. MRD statuses stratified by 0.1% and individual threshold were termed as 0.1%‐MRD and individual‐MRD, respectively. The patients of individual‐MRD neg showed significantly better survival compared with those of 0.1%‐MRD neg /individual‐MRD pos or 0.1%‐MRD pos . Multivariate analysis showed that when time points of complete remission, post the first and second consolidation courses, were considered, only individual‐MRD post second consolidation presented independent prognostic value. Notably, in patients of cytogenetic/molecular low‐risk (LR) or intermediate‐risk (IR), the individual‐MRD status could identify the patients with significantly different outcomes, while 0.1%‐MRD status could not. Furthermore, among the patients of the LR or IR group which received chemotherapy only, those with individual‐MRD neg status presented favorable survival, which was comparable with that of the patients accepted allogeneic hematopoietic stem cell transplantation (ASCT). This approach is useful in the selection of an ASCT strategy for clinical practice." @default.
- W2911487675 created "2019-02-21" @default.
- W2911487675 creator A5015897162 @default.
- W2911487675 creator A5025565899 @default.
- W2911487675 creator A5049061801 @default.
- W2911487675 creator A5067338319 @default.
- W2911487675 creator A5071144897 @default.
- W2911487675 creator A5071374332 @default.
- W2911487675 creator A5077604881 @default.
- W2911487675 creator A5079325210 @default.
- W2911487675 date "2019-02-21" @default.
- W2911487675 modified "2023-10-13" @default.
- W2911487675 title "Identifying leukemia‐associated immunophenotype‐based individualized minimal residual disease in acute myeloid leukemia and its prognostic significance" @default.
- W2911487675 cites W1489279917 @default.
- W2911487675 cites W1880892126 @default.
- W2911487675 cites W1963777403 @default.
- W2911487675 cites W1967685674 @default.
- W2911487675 cites W1976003274 @default.
- W2911487675 cites W1981462221 @default.
- W2911487675 cites W2007302457 @default.
- W2911487675 cites W2023267905 @default.
- W2911487675 cites W2025186846 @default.
- W2911487675 cites W2038242472 @default.
- W2911487675 cites W2048369602 @default.
- W2911487675 cites W2071206691 @default.
- W2911487675 cites W2110096889 @default.
- W2911487675 cites W2124159210 @default.
- W2911487675 cites W2128541003 @default.
- W2911487675 cites W2130792203 @default.
- W2911487675 cites W2138265677 @default.
- W2911487675 cites W2141773875 @default.
- W2911487675 cites W2159875685 @default.
- W2911487675 cites W2162411731 @default.
- W2911487675 cites W2168438358 @default.
- W2911487675 cites W2214515641 @default.
- W2911487675 cites W2276580523 @default.
- W2911487675 cites W2290759365 @default.
- W2911487675 cites W2296830845 @default.
- W2911487675 cites W2336690489 @default.
- W2911487675 cites W2419140434 @default.
- W2911487675 cites W2527290204 @default.
- W2911487675 cites W2559537906 @default.
- W2911487675 cites W2570086182 @default.
- W2911487675 cites W2587434196 @default.
- W2911487675 cites W2715749014 @default.
- W2911487675 cites W2725930552 @default.
- W2911487675 cites W2727410306 @default.
- W2911487675 cites W2768422444 @default.
- W2911487675 cites W2783450169 @default.
- W2911487675 cites W2790959055 @default.
- W2911487675 cites W3149097951 @default.
- W2911487675 doi "https://doi.org/10.1002/ajh.25431" @default.
- W2911487675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30734356" @default.
- W2911487675 hasPublicationYear "2019" @default.
- W2911487675 type Work @default.
- W2911487675 sameAs 2911487675 @default.
- W2911487675 citedByCount "21" @default.
- W2911487675 countsByYear W29114876752019 @default.
- W2911487675 countsByYear W29114876752020 @default.
- W2911487675 countsByYear W29114876752021 @default.
- W2911487675 countsByYear W29114876752022 @default.
- W2911487675 countsByYear W29114876752023 @default.
- W2911487675 crossrefType "journal-article" @default.
- W2911487675 hasAuthorship W2911487675A5015897162 @default.
- W2911487675 hasAuthorship W2911487675A5025565899 @default.
- W2911487675 hasAuthorship W2911487675A5049061801 @default.
- W2911487675 hasAuthorship W2911487675A5067338319 @default.
- W2911487675 hasAuthorship W2911487675A5071144897 @default.
- W2911487675 hasAuthorship W2911487675A5071374332 @default.
- W2911487675 hasAuthorship W2911487675A5077604881 @default.
- W2911487675 hasAuthorship W2911487675A5079325210 @default.
- W2911487675 hasBestOaLocation W29114876751 @default.
- W2911487675 hasConcept C126322002 @default.
- W2911487675 hasConcept C143998085 @default.
- W2911487675 hasConcept C196166836 @default.
- W2911487675 hasConcept C203014093 @default.
- W2911487675 hasConcept C2778461978 @default.
- W2911487675 hasConcept C2778729363 @default.
- W2911487675 hasConcept C2779823535 @default.
- W2911487675 hasConcept C38180746 @default.
- W2911487675 hasConcept C553184892 @default.
- W2911487675 hasConcept C71924100 @default.
- W2911487675 hasConceptScore W2911487675C126322002 @default.
- W2911487675 hasConceptScore W2911487675C143998085 @default.
- W2911487675 hasConceptScore W2911487675C196166836 @default.
- W2911487675 hasConceptScore W2911487675C203014093 @default.
- W2911487675 hasConceptScore W2911487675C2778461978 @default.
- W2911487675 hasConceptScore W2911487675C2778729363 @default.
- W2911487675 hasConceptScore W2911487675C2779823535 @default.
- W2911487675 hasConceptScore W2911487675C38180746 @default.
- W2911487675 hasConceptScore W2911487675C553184892 @default.
- W2911487675 hasConceptScore W2911487675C71924100 @default.
- W2911487675 hasFunder F4320321001 @default.
- W2911487675 hasIssue "5" @default.
- W2911487675 hasLocation W29114876751 @default.
- W2911487675 hasLocation W29114876752 @default.
- W2911487675 hasOpenAccess W2911487675 @default.
- W2911487675 hasPrimaryLocation W29114876751 @default.